Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
KemPharm to Present at Two Healthcare Investor Conferences During September 2018 | ||||||
By: Nasdaq / GlobeNewswire - 05 Sep 2018 | Back to overview list |
|||||
CORALVILLE, Iowa, Sept. 05, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that its President and Chief Executive Officer, Travis C. Mickle, Ph.D., will present at the Janney Montgomery Scott Healthcare Conference being held September 17-18, 2018. He will also attend one-on-one investor meetings at the Oppenheimer & Co. Fall Summit Focused on Specialty Pharma and Rare Disease, to be held September 26-27, 2018. Both conferences are in New York City. Details of KemPharm's presentation and one-on-one investor meetings are as follows: Conference: Janney Montgomery Scott Healthcare Conference 2018 Conference: Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease The Janney Healthcare Conference presentation will be webcast and available on the Investor Relations section under “Events & Presentations” on the Company's website at http://investors.kempharm.com/. About KemPharm
|
||||||
|
||||||
Copyright 2018 Nasdaq / GlobeNewswire | Back to overview list |